Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Waters Corporation is a global analytical instruments company that designs, manufactures, and sells high-performance laboratory equipment, consumables, and software used for chemical, pharmaceutical, life sciences, food safety, environmental, and industrial analysis. The company operates primarily in the analytical instrumentation and life sciences tools industries, with a strong focus on technologies that enable the separation, identification, and quantification of complex chemical and biological substances.
The company’s primary revenue drivers are its Chromatography and Mass Spectrometry businesses, complemented by recurring revenue from consumables, service contracts, and software. Waters serves pharmaceutical and biotechnology companies, academic and government research institutions, clinical laboratories, and industrial customers. Its strategic positioning is supported by a strong installed base, high switching costs, and deep regulatory expertise, particularly in regulated pharmaceutical quality control environments. Waters was founded in 1958 by James L. Waters and has evolved from a chromatography-focused company into a diversified analytical science leader through sustained internal innovation and targeted acquisitions.
Business Operations
Waters generates revenue through two primary operating segments: Waters and TA Instruments. The Waters segment focuses on liquid chromatography (LC), ultra-performance liquid chromatography (UPLC), mass spectrometry (MS), informatics, and related consumables and services. The TA Instruments segment provides thermal analysis, rheology, and microcalorimetry instruments used in materials science, polymers, and pharmaceutical research and quality control.
Operations are global, with manufacturing, research and development, sales, and service infrastructure across North America, Europe, and Asia-Pacific. The company controls proprietary instrument platforms, column chemistries, detector technologies, and software ecosystems that integrate hardware and data workflows. Key subsidiaries include TA Instruments, which operates with a distinct brand and customer base, and regional sales and service entities that support localized customer engagement. Waters also maintains long-term relationships with pharmaceutical manufacturers and regulatory bodies, reinforcing its role in compliant analytical testing.
Strategic Position & Investments
Waters’ strategic direction emphasizes innovation in high-sensitivity analytical technologies, expansion of recurring revenue streams, and deeper penetration into biopharmaceutical, clinical, and applied markets. Growth initiatives include advancing biologics characterization, enhancing compliance-focused software solutions, and expanding service offerings tied to its installed base. The company has consistently invested in research and development to maintain leadership in chromatography and mass spectrometry performance.
A major strategic investment was the acquisition of TA Instruments, which diversified Waters into materials characterization and thermal analysis, reducing reliance on life sciences end markets alone. The company continues to invest in emerging areas such as large-molecule analysis, bioprocess monitoring, and data-integrated laboratory workflows. While Waters has made selective bolt-on acquisitions, its strategy is primarily driven by organic growth and platform innovation rather than frequent large-scale mergers.
Geographic Footprint
Waters Corporation is headquartered in Milford, Massachusetts, United States, and operates in more than 35 countries worldwide. Its largest market is North America, followed by significant operations in Europe and Asia-Pacific, where demand is driven by pharmaceutical manufacturing, academic research, and industrial testing.
The company maintains manufacturing and R&D facilities in the United States, Ireland, United Kingdom, Singapore, and other locations, supporting a global supply chain and regional customization. Waters has a strong presence in developed markets and continues to expand its influence in emerging regions, particularly China and India, where pharmaceutical and industrial analytical demand is growing.
Leadership & Governance
Waters Corporation is led by an experienced executive team with deep expertise in analytical sciences, regulated industries, and global operations. The leadership emphasizes operational excellence, customer-centric innovation, and disciplined capital allocation, with a strategic vision centered on long-term value creation through scientific leadership and recurring revenue growth.
Key executives include:
- Udit Batra – President and Chief Executive Officer
- Amir Aghdaei – Senior Vice President and Chief Financial Officer
- Pat Behm – Senior Vice President, Waters Division
- John Gouveia – Senior Vice President, TA Instruments
- Shawn Davidson – Senior Vice President, Global Operations
The company is governed by a board of directors with experience spanning life sciences, industrial technology, finance, and global corporate leadership, supporting oversight aligned with shareholder and regulatory expectations.